IN192526B - - Google Patents

Info

Publication number
IN192526B
IN192526B IN982DE2001A IN192526B IN 192526 B IN192526 B IN 192526B IN 982DE2001 A IN982DE2001 A IN 982DE2001A IN 192526 B IN192526 B IN 192526B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Jitendra Sattigeri
Jasbir Singh Arora
Sanjay Malhotra
Ashwani Kumar Varma
Mohammad Salman
Original Assignee
Ranbaxy Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab filed Critical Ranbaxy Lab
Priority to IN982DE2001 priority Critical patent/IN192526B/en
Priority to US10/490,540 priority patent/US20040249147A1/en
Priority to PCT/IB2002/003942 priority patent/WO2003027103A1/en
Priority to EP02799452A priority patent/EP1432704A1/en
Priority to ZA200402531A priority patent/ZA200402531B/en
Publication of IN192526B publication Critical patent/IN192526B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IN982DE2001 2001-09-25 2001-09-25 IN192526B (pt)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IN982DE2001 IN192526B (pt) 2001-09-25 2001-09-25
US10/490,540 US20040249147A1 (en) 2001-09-25 2002-09-24 Synthesis of key azole-antifungal intermediates
PCT/IB2002/003942 WO2003027103A1 (en) 2001-09-25 2002-09-24 Synthesis of key azole-antifungal intermediates
EP02799452A EP1432704A1 (en) 2001-09-25 2002-09-24 Synthesis of key azole-antifungal intermediates
ZA200402531A ZA200402531B (en) 2001-09-25 2004-03-31 Process for the preparation of fat dissolving dosage form.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN982DE2001 IN192526B (pt) 2001-09-25 2001-09-25

Publications (1)

Publication Number Publication Date
IN192526B true IN192526B (pt) 2004-04-24

Family

ID=11097113

Family Applications (1)

Application Number Title Priority Date Filing Date
IN982DE2001 IN192526B (pt) 2001-09-25 2001-09-25

Country Status (5)

Country Link
US (1) US20040249147A1 (pt)
EP (1) EP1432704A1 (pt)
IN (1) IN192526B (pt)
WO (1) WO2003027103A1 (pt)
ZA (1) ZA200402531B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007201276B2 (en) * 2002-03-12 2009-11-05 Merck Sharp & Dohme Corp. Substituted amides
CN102675309B (zh) * 2012-04-20 2015-08-05 浙江工业大学 一种三唑并吡啶衍生物在制备抗真菌药物中的应用
TW201636329A (zh) 2015-02-02 2016-10-16 佛瑪治療公司 作為hdac抑制劑之雙環[4,6,0]異羥肟酸
EA201792673A1 (ru) 2015-02-02 2018-04-30 Форма Терапьютикс, Инк. 3-арил-4-амидобициклические [4,5,0] гидроксамовые кислоты в качестве ингибиторов hdac
EP3472131B1 (en) 2016-06-17 2020-02-19 Forma Therapeutics, Inc. 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW206224B (pt) * 1989-12-14 1993-05-21 Takeda Pharm Industry Co Ltd
EP0548553A1 (en) * 1991-11-25 1993-06-30 Takeda Chemical Industries, Ltd. Optically active azole compounds, their production and use
TW218017B (pt) * 1992-04-28 1993-12-21 Takeda Pharm Industry Co Ltd
TW297813B (pt) * 1993-09-24 1997-02-11 Takeda Pharm Industry Co Ltd
TW318841B (pt) * 1995-02-17 1997-11-01 Takeda Pharm Industry Co Ltd
WO1996025410A1 (en) * 1995-02-17 1996-08-22 Takeda Chemical Industries, Ltd. Azole compounds, their production and use
CA2201478A1 (en) * 1995-08-02 1997-02-13 J. Uriach & Cia S.A. New carboxamides with antifungal activity
EP0933368A1 (en) * 1998-02-02 1999-08-04 SSP Co., Ltd. Triazole derivative or salt thereof, preparation process thereof and pharmaceutical containing said compound as an effective ingredient (antimycotic)
US6133485A (en) * 1998-04-15 2000-10-17 Synphar Laboratories, Inc. Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols
AU3402301A (en) * 2000-03-07 2001-09-17 Ranbaxy Laboratories Limited Azole compounds as therapeutic agents for fungal infections

Also Published As

Publication number Publication date
EP1432704A1 (en) 2004-06-30
ZA200402531B (en) 2004-10-15
WO2003027103A1 (en) 2003-04-03
US20040249147A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
BE2022C531I2 (pt)
BE2022C502I2 (pt)
BE2022C547I2 (pt)
BE2017C056I2 (pt)
BE2017C051I2 (pt)
BE2017C032I2 (pt)
BE2016C051I2 (pt)
BE2015C046I2 (pt)
BE2014C052I2 (pt)
BE2014C036I2 (pt)
BE2014C026I2 (pt)
BE2017C050I2 (pt)
BE2014C004I2 (pt)
BE2014C006I2 (pt)
BE2011C034I2 (pt)
BE2007C047I2 (pt)
AU2002307149A8 (pt)
BRPI0209186B1 (pt)
BE2016C021I2 (pt)
BE2014C008I2 (pt)
CH1379220H1 (pt)
BRPI0204884B1 (pt)
BE2017C059I2 (pt)
BRPI0101486B8 (pt)
BE2012C051I2 (pt)